医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(R,S)-1-对甲苯磺酰基甘油 | (+/-)-2,3-dihydroxypropyl tosylate | 73073-07-1 | C10H14O5S |
|
(R,R)-2,6-双(4-异丙基-2-恶唑啉-2-基)吡啶 | (R,R)-2,6-bis(4-isopropyl-2-oxazolin-2-yl)pyridine | 131864-67-0 | C17H23N3O2 |
|
(R,R)-1,2-双(甲磺酰基氧基甲基)环己烷 | (1R,2R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane | 186204-35-3 | C10H20O6S2 |
|
(R,E)-5-([1,1'-联苯]-4-基)-4-[(叔丁氧羰基)氨基]-2-甲基-2-戊烯酸 | (R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methyl-2-pentenoic acid | 1012341-48-8 | C23H27NO4 |
|
(R)-雷奈佐利 | linezolid | 872992-20-6 | C16H20FN3O4 |
|
(R)-酮咯酸 | R-(+)-ketorolac | 66635-93-6 | C15H13NO3 |
|
(R)-色满-2-基甲胺盐酸盐 | (2R)-3,4-dihydro-2H-chromen-2-ylmethylamine hydrochloride | 437763-66-1 | C10H13NO*ClH |
|
(R)-甲基2-氧代噁唑啉-4-羧酸 | (R)-2-oxo-oxazolidine-4-carboxylic acid methyl ester | 144542-43-8 | C5H7NO4 |
|
(R)-环丙烷-1,2,3-三羧酸三乙酯 | trans,meso-cyclopropanetricarboxylic acid triethyl ester | 13949-99-0 | C12H18O6 |
|
(R)-氟甲喹 | R-(+)-flumequine | 215178-95-3 | C14H12FNO3 |
|
(R)-普瑞巴林 | (R)-pregabalin | 148553-51-9 | C8H17NO2 |
|
(R)-四氢呋喃甲酸 | (R)-tetrahydro-2-furoic acid | 87392-05-0 | C5H8O3 |
|
(R)-四氢-2H-吡喃-3-胺盐酸盐 | (3R)-tetrahydropyran-3-amine | 1071829-82-7 | C5H11NO |
|
(R)-唑哚洛尔 | R-(+)-1-tert-butylamino-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol | 26839-76-9 | C13H24N4O3S |
|
(R)-哌嗪-2-羧酸二盐酸盐 | (R)-Piperazine-2-carboxylic acid dihydrochloride | 126330-90-3 | C5H12Cl2N2O2 |
|
(R)-哌啶-3-甲酸甲酯 | (R)-methyl piperidine-3-carboxylate | 164323-85-7 | C7H13NO2 |
|
(R)-吲哚啉-2-羧酸 | (R)-indoline-2-carboxylic acid | 98167-06-7 | C9H9NO2 |
|
(R)-叔丁基 2-(2-羟基乙基)吡咯烷-1-羧酸 | tert-butyl (2R)-2-(2-hydroxyethyl)pyrrolidine-1-carboxylate | 132482-06-5 | C11H21NO3 |
|
(R)-六氢-噁唑并[3,4-a]吡嗪-3-酮盐酸盐 | (R)-hexahydro-oxazolo[3,4-a]pyrazin-3-one hydrochloride | 1212327-95-1 | C6H10N2O2*ClH |
|
(R)-依法韦仑 | (R)-efavirenz | 154801-74-8 | C14H9ClF3NO2 |
|
(R)-二氢-4-丙基-2(3H)-呋喃酮 | (R)-4-propyldihydrofuran-2(3H)-one | 63095-51-2 | C7H12O2 |
|
(R)-β2-高缬氨酸 | (R)-2-(Aminomethyl)-3-methylbutanoic acid hydrochloride | 1276055-45-8 | C6H13NO2*ClH |
|
(R)-N-[3-(3-氟-(4-吗啉基)苯基)-2-氧代-5-噁唑烷基]甲醇甲磺酸酯 | [N-3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl methanesulfonate | 174649-09-3 | C15H19FN2O6S |
|
(R)-N-Boc-2-羟甲基吗啉 | (R)-2-hydroxymethylmorpholine-4-carboxylic acid tert-butyl ester | 135065-71-3 | C10H19NO4 |
|
(R)-N-1-Boc-N-4-Cbz-2-哌嗪甲酸 | (2R)-4-[(benzyloxy)carbonyl]-1-[(tert-butoxy)carbonyl]piperazine-2-carboxylic acid | 138775-02-7 | C18H24N2O6 |
|
(R)-N-(1-(3-(苄氧基)-2-羟基丙基)-2-(1-(苄氧基)-2-甲基丙-2-基)-6- | (R)-N-(1-(3-(benzyloxy)-2-hydroxypropyl)-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-5-yl)-1-(2,2-difluorobenzo [d][1,3]dioxol-5-yl)cyclopropanecarboxamide | 1294504-68-9 | C40H39F3N2O6 |
|
(R)-9-((三异丙基硅基)氧基-6,7,8,9-四氢-5H-环庚基[B]吡啶-5-酮盐酸盐 | (R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one | 1190363-45-1 | C19H31NO2Si |
|
(R)-6-环戊基-6-[2-(2,6-二乙基吡啶-4-基)乙基]-3-[(5,7-二甲基-[1,2,4]三唑并[1,5-a]嘧啶-2-基)甲基]-4-羟基-5,6-二氢-2H-吡喃-2-酮 | filibuvir | 877130-28-4 | C29H37N5O3 |
|
(R)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮 | (R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | 101328-85-2 | C11H13N3O |
|
(R)-6,7-二氢-5H-吡咯并[1,2-a]咪唑-7-醇 | (R)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol | 1221187-73-0 | C6H8N2O |
|
(R)-5-溴-3-(1-甲基-2-吡咯烷基甲基)-1H-吲哚 | (R)-5-bromo-3-(N-methylpyrrolidine-2-ylmethyl)-1H-indole | 143322-57-0 | C14H17BrN2 |
|
(R)-5-氨基-2-哌啶酮盐酸盐 | (5R)-5-aminopiperidin-2-one hydrochloride | 1003021-01-9 | C5H10N2O*ClH |
|
(R)-5-[2-[(5,6-二乙基-2,3-二氢-1H-茚-2-基)氨基]-1-羟基乙基]-8-(苄氧基)-2(1H)-喹啉酮 | 8-(phenylmethoxy)-5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-(1H)-quinolin-2-one | 435273-75-9 | C31H34N2O3 |
|
(R)-5-[2-(2,5-二氟苯基)吡咯烷-1-基]吡唑并[1,5-A]嘧啶 | (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidine | 1223404-89-4 | C16H14F2N4 |
|
(R)-5-(2-(2,5-二氟苯基)吡咯烷-1-基)-3-硝基吡唑并[1,5-A]嘧啶 | (R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-nitropyrazolo[1,5-a]pyrimidine | 1223404-90-7 | C16H13F2N5O2 |
|
(R)-4-羟基-N,N-二苯基-2-戊炔酰胺 | (R)-4-hydroxy-N,N-diphenylpent-2-ynamide | 899809-61-1 | C17H15NO2 |
|
(R)-4-Boc-2-甲基哌嗪 | (R)-tert-butyl 3-methylpiperazine-1-carboxylate | 163765-44-4 | C10H20N2O2 |
|
(R)-4-(2,4-二甲氧基苄基)-3-甲基哌嗪-2-酮 | (R)-4-(2,4-dimethoxybenzyl)-3-methylpiperazin-2-one | 1383146-20-0 | C14H20N2O3 |
|
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-b]吡啶-4-基苯甲酰胺 | (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide | 199433-58-4 | C16H16N4O |
|
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺盐酸盐 | Y-39983 | 471843-75-1 | C16H16N4O*ClH |
|
(R)-3-苯基哌啶 | (R)-3-phenylpiperidine | 430461-56-6 | C11H15N |
|
(R)-3-苯基吡咯烷盐酸盐 | (R)-3-phenylpyrrolidine hydrochloride | 851000-46-9 | C10H13N*ClH |
|
(R)-3-羟基吡咯烷盐酸盐 | (R)-3-hydroxypyrrolidine hydrochloride | 104706-47-0 | C4H9NO*ClH |
|
(R)-3-甲氧基吡咯烷盐酸盐 | (R)-3-methoxypyrrolidine hydrochloride | 474707-30-7 | C5H11NO*ClH |
|
(R)-3-甲基哌嗪-2-酮 | (R)-3-methylpiperazin-2-one | 922178-61-8 | C5H10N2O |
|
(R)-3-甲基吡咯烷盐酸盐 | (R)-3-methylpyrrolidine hydrochloride | 235093-98-8 | C5H11N*ClH |
|
(R)-3-氰基-2-羟基-N,N,N-三甲基-1-丙铵氯化物 | L-carnitinenitrile chloride | 2788-28-5 | C7H15N2O*Cl |
|
(R)-3-氨基丁醇 | (R)-3-amino-1-butanol | 61477-40-5 | C4H11NO |
|
(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸 | (R)-3-amino-4-(2,4,5-trifluorophenyl)butyric acid | 936630-57-8 | C10H10F3NO2 |
|
(R)-3-叔丁氧羰基氨基吡咯烷 | 3-N-tert-butoxycarbonyl-3-(R)-aminopyrrolidine | 122536-77-0 | C9H18N2O2 |
|